Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer.
Abhishek MahajanDevendra GoyalUjjwal AgarwalVijay PatilShreya ShuklaVanita NoronhaAmit JoshiNandini MenonKumar PrabhashPublished in: Exploration of targeted anti-tumor therapy (2023)
In both univariate and multivariate analyses, this study demonstrated the statistical significance of sarcopenia, SMD, and mALI as predictive factors for OS. Additionally, sarcopenia and SMD were also found to be statistically significant factors in predicting PFS. These biomarkers could potentially help triage patients for active nutritional intervention for better outcomes.